On 24 March 2023, the NMPA issued four regulations to accompany the Anti-Monopoly Law, namely the Regulations on the Suppression of Abuse of Administrative Power to Exclude and Restrict Competition, the Regulations on the Prohibition of Monopoly Agreements, the Regulations on the Prohibition of Abuse of a Dominant Market Position and the Regulations on the Review of Concentration of Operators, which will come into effect on 15 April 2023. more…
On March 21,2023, in order to further promote the high-quality development of the medical device industry, Zhejiang Provincial MPA formulated and issued the Implementation Opinions on Optimizing the Review and approval of Medical device Registration (later called Implementation more…
It has been recently learned that according to the notice of the NMPA, the “Cerebrovascular Interventional Surgery Auxiliary Operating System” of Endo Medical, the holding subsidiary of Beijing Vas Medical, has been approved by NMPA, and the registration certificate number is National Instrument Registration Permit 20233010311. more…
From March 1 to March 4, 2023, the 13th China International Medical Device Regulatory Forum (CIMDR) was held in Fuzhou, Fujian Province, China. CIMDR is one of the most important regulatory conferences in China on medical device, and NMPA, CMDE and related experts attended this forum to release the latest regulatory updates. The major insights from the 13th CIMDR are listed as below. more…
Data show that in 2021, the market size of China’s medical aesthetic device industry is 54.37 billion yuan, and it is expected that the market size of China’s medical aesthetic device industry will reach 77.48 billion yuan in 2023 and is expected to reach a scale of 100 million yuan in 2025. more…
The list of domestic device market was compiled by Zhongcheng Data based on the public data from the purchasing platforms of provinces and municipalities, the official websites of major hospitals and third-party platforms. The list only shows domestic brands. more…
